UPADACITINIB EFFECT ON PRURITUS IN MODERATE-TO-SEVERE ATOPIC DERMATITIS; FROM A PHASE 2B RANDOMIZED, PLACEBO-CONTROLLED TRIAL

被引：12
|
作者：
Beck, L.
Hong, C.
Hu, X.
Chen, S.
Calimlim, B.
Teixeira, H.
Guttman-Yassky, E.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2018年 / 121卷 / 05期
关键词：
D O I：
10.1016/j.anai.2018.09.063
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
D500
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of orismilast, a potent PDE4B/D inhibitor, in adults with moderate-to-severe atopic dermatitis: a phase 2b randomized, double-blind, placebo-controlled clinical trial (ADESOS)
    Silverberg, Jonathan
    Eichenfield, Lawrence
    Blauvelt, Andrew
    Irvine, Alan D.
    Langley, Richard
    Guttman, Emma
    Warren, Richard
    French, Lars
    Pedersen, Claus Bang
    Carlsson, Anna
    Jensen, Morten Lind
    Sommer, Morten O. A.
    Kjoller, Kim
    Simpson, Eric
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : 68 - 69
  • [32] Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a randomized, placebo-controlled clinical trial
    Tsianakas, A.
    Luger, T. A.
    Radin, A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (02) : 406 - 414
  • [33] Efficacy and safety of topically applied therapeutic ammonia oxidising bacteria in adults with mild-to-moderate atopic dermatitis and moderate-to-severe pruritus: a randomised, double-blind, placebo-controlled, dose-ranging, phase 2b trial
    Silverberg, Jonathan I.
    Lio, Peter A.
    Simpson, Eric L.
    Li, Connie
    Brownell, Daniel R.
    Gryllos, Ioannis
    Ng-Cashin, Judith
    Krueger, Todd
    Swaidan, Victoria R.
    Bliss, Robin L.
    Kim, Hyun D.
    [J]. ECLINICALMEDICINE, 2023, 60
  • [34] Dupilumab with concomitant topical corticosteroids in moderate-to-severe atopic dermatitis: A randomised, placebo-controlled phase 3 clinical trial (CHRONOS)
    Blauvelt, A.
    Gooderham, M.
    Foley, P.
    Griffiths, C. E. M.
    Cather, J. C.
    de Bruin-Weller, M.
    Zhu, X.
    Graham, N. M. H.
    Pirozzi, G.
    Shumel, B.
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2017, 58 : 55 - 55
  • [35] Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial
    Blauvelt, Andrew
    Teixeira, Henrique D.
    Simpson, Eric L.
    Costanzo, Antonio
    De Bruin-Weller, Marjolein
    Barbarot, Sebastien
    Prajapati, Vimal H.
    Lio, Peter
    Hu, Xiaofei
    Wu, Tianshuang
    Liu, John
    Ladizinski, Barry
    Chu, Alvina D.
    Eyerich, Kilian
    [J]. JAMA DERMATOLOGY, 2021, 157 (09) : 1047 - 1055
  • [36] A phase 2b, randomized, double-blinded, parallel-group, placebo-controlled, international, multicenter, study to evaluate the efficacy and safety of rezpegaldesleukin in adults with moderate-to-severe atopic dermatitis
    Gooderham, Melinda
    Lynde, Charles
    Alam, Maryam Shayesteh
    Sadick, Neil
    Rohan, Craig A.
    Werschler, William Philip
    Hebert, Adelaide A.
    Laquer, Vivian T.
    Sauder, Maxwell
    Del Rosso, James Q.
    Rodgers, Timothy
    Tan, Ricardo
    Schleicher, Stephen
    Murrell, Dedee F.
    Fernandez-Penas, Pablo
    Reich, Adam
    Gkalpakiotis, Spyridon
    Ruiz, Juan Ruano
    Wollenberg, Andreas
    Szepietowski, Jacek C.
    Sticherling, Michael
    Weyergraf, Ansgar J.
    Hadzavdic, Suzana Ljubojevic
    Baran, Wojciech
    Vilchez, Trinidad Montero
    Eniko, Telegdy
    Sebastian, Michael
    Chaudhry, Sohail
    Lee, Zachary
    Yu, Danni
    Liu, Yi
    Waltz, Wang
    Gilbert, Jenny
    Elko-Simms, Lucinda M.
    Fanton, Christie
    Jue, Charleen
    Tagliaferri, Mary
    Zalevsky, Jonathan
    Rosmarin, David
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : 105 - 107
  • [37] Dupilumab does not affect correlates of vaccine-induced immunity: A randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis
    Blauvelt, Andrew
    Simpson, Eric L.
    Tyring, Stephen K.
    Purcell, Lisa A.
    Shumel, Brad
    Petro, Christopher D.
    Akinlade, Bolanle
    Gadkari, Abhijit
    Eckert, Laurent
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Evans, Robert
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (01) : 158 - +
  • [38] EFFICACY AND SAFETY OF TRALOKINUMAB IN A KOREAN SUBPOPULATION OF PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: A SUBANALYSIS OF ECZTRA 2, A PHASE 3, MONOTHERAPY, RANDOMIZED, DOUBLEBLIND, PLACEBO-CONTROLLED TRIAL
    Kim, Kyu Han
    Son, Sang Wook
    Lee, Yang Won
    Simpson, Eric L.
    Kuznetsova, Alexandra
    Cho, Sang Hyun
    [J]. ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 63 - 63
  • [39] Health-related quality of life with tralokinumab in moderate-to-severe atopic dermatitis A phase 2b randomized study
    Silverberg, Jonathan, I
    Guttman-Yassky, Emma
    Gooderham, Melinda
    Worm, Margitta
    Rippon, Stephanie
    O'Quinn, Sean
    van der Merwe, Rene
    Kragh, Nana
    Kurbasic, Azra
    Wollenberg, Andreas
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 126 (05) : 576 - +
  • [40] Durability of Response to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis After Treatment Discontinuation in a Phase 2b Trial
    Gooderham, Melinda J.
    Girolomoni, Giampiero
    Moore, Julian O.
    Silverberg, Jonathan, I
    Bissonnette, Robert
    Forman, Seth
    Peeva, Elena
    Biswas, Pinaki
    Valdez, Hernan
    Chan, Gary
    [J]. DERMATOLOGY AND THERAPY, 2022, 12 (09) : 2077 - 2085
12345